http://www.maniacsolutions.com/marketing-edge-sf/
In Abbott's investigational MitraClip (R) shows results strong security system and Improving Clinical Outcomes … Abbott (NYSE: ABT) announced today new data from the landmark EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) trial, which provided additional details on the safety and clinical benefit Abbott Research MitraClip (R) of the two causes of mitral regurgitation (MR) – Functional MRI (FMR) or degenerative MR (DMR). In the EVEREST II trial, 30-day significant adverse events …
J RockA & Sarai Knowledge – (Pt. 1 Intro) LIVE in SF City Hall Fashion Show